Checkpoint Trends Ltd.
Snapshot View

4.72 ▼0%

20 February 2023, 04:01:00 PM

Overview View Details >>

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.rubramed.com
Market Cap 2.58 Cr.
Enterprise Value(EV) 2.74 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.02 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 286.78 Trailing Twelve Months Ending 2022-12
Industry PE 35.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 0.49 Trailing Twelve Months Ending 2022-12
Price to Book Value 9.61 Calculated using Price: 4.72
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.55 Cr. 5,468,300 Shares
FaceValue 10
Company Profile
The main object of the company is to cater to wholesale and retail markets with distribution of medicines and other medical and surgical products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
1 Month
3 Month
+4.89%
6 Month
+22.92%
1 Year
+60.0%
2 Year
+95.04%
5 Year
+52.26%
10 Year
+98.32%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -1.68 -159.53 -1.76 8.48 -48.73 -4.59 12.20 2.02 -13.95
Return on Capital Employed (%) -1.59 -150.53 -1.75 9.13 -32.23 -1.87 7.98 1.37 -3.70
Return on Assets (%) -1.55 -145.00 -1.47 6.88 -24.39 -1.51 4.35 0.68 -4.17

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 3 0 0 0 1 1 1 1 1 1
Non Curr. Liab. 0 0 0 0
Curr. Liab. 0 0 0 0 0 0 0
Minority Int.
Equity & Liab. 4 0 0 1 1 1 1 1 1 1
Non Curr. Assets 3 0 0 0 0 0 0 0 0 0
Curr. Assets 0 0 0 0 1 1 1 1 1 1
Misc. Exp. not W/O
Total Assets 4 0 0 1 1 1 1 1 1 1

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 0 0 2 1 1 0 2 2
Other Income 0
Total Income 0 0 2 1 1 0 2 2
Total Expenditure 0 0 0 0 -2 -1 -1 0 -2 -2
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest
Depreciation
Taxation 0 0 0
Exceptional Items -3 0 0 0
PAT 0 -3 0 0 0 0 0 0 0 0
Adjusted EPS 0 -6 0 0 0 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0 1 -1
Cash Fr. Inv.
Cash Fr. Finan. 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 1 -1
Cash & Cash Eqvt 0 0 0 0 0 0 0 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 30 Mar 2023
Closure of Trading Window
Pursuant to the Companys Securities Dealing Code the Trading Window for dealing in the Companys Equity Shares will remain closed from Saturday April 1 2023 for all Designated Employees of the Company.The closure is in connection with the declaration of Audited financial results of the Company for the quarter and year ending March 31 2023. The Trading Window will open 48 hours after the said financial results are declared to the Stock Exchanges.
Tue, 14 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper publication of Unaudited Financial Results for the quarter and Nine Month ended December 31 2022
Mon, 13 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting
The Board of Directors of the Company at its meeting held on Monday February 13 2023 inter alia has considered and approved the Unaudited Standalone Financial Results along with Limited review report for the quarter ended December 31 2022

Technical Scans View Details >>

No Scans Found

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 199,500.20 1,750.00 +0.5%
Redington Ltd. 13,024.71 166.65 -1.6%
MMTC Ltd. 4,185.00 27.90 -0.4%
Landmark Cars Ltd. 2,153.60 546.90 +7.4%
Optiemus Infracom Ltd. 1,767.37 207.95 +2.7%
SIRCA Paints India Ltd. 1,765.39 645.35 +0.3%
Polo Queen Industrial & Fintech Ltd. 1,370.87 40.80 -3.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-12 97.09 1,750.00 +0.5%
Redington Ltd. Consolidated 2022-12 9.11 166.65 -1.6%
MMTC Ltd. Consolidated 2022-12 2.50 27.90 -0.4%
Landmark Cars Ltd. Consolidated 2022-03 33.09 546.90 +7.4%
Optiemus Infracom Ltd. Consolidated 2022-12 64.96 207.95 +2.7%
SIRCA Paints India Ltd. Consolidated 2022-12 41.31 645.35 +0.3%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-12 527.27 40.80 -3.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-12 6.20 1,750.00 +0.5%
Redington Ltd. Consolidated 2022-12 1.97 166.65 -1.6%
MMTC Ltd. Consolidated 2022-12 3.04 27.90 -0.4%
Landmark Cars Ltd. Consolidated 2022-03 2.66 546.90 +7.4%
Optiemus Infracom Ltd. Consolidated 2022-12 4.89 207.95 +2.7%
SIRCA Paints India Ltd. Consolidated 2022-12 6.91 645.35 +0.3%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-12 8.39 40.80 -3.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 1.82 1,750.00 +0.5%
Redington Ltd. Consolidated 2022-03 0.11 166.65 -1.6%
MMTC Ltd. Consolidated 2022-03 -17.70 27.90 -0.4%
Landmark Cars Ltd. Consolidated 2022-03 1.02 546.90 +7.4%
Optiemus Infracom Ltd. Consolidated 2022-03 0.13 207.95 +2.7%
SIRCA Paints India Ltd. Consolidated 2022-03 0.00 645.35 +0.3%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.10 40.80 -3.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 2.41 1,750.00 +0.5%
Redington Ltd. Consolidated 2022-03 24.61 166.65 -1.6%
MMTC Ltd. Consolidated 2022-03 0.00 27.90 -0.4%
Landmark Cars Ltd. Consolidated 2022-03 31.70 546.90 +7.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.28 207.95 +2.7%
SIRCA Paints India Ltd. Consolidated 2022-03 12.99 645.35 +0.3%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.89 40.80 -3.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 2.41 1,750.00 +0.5%
Redington Ltd. Consolidated 2022-03 24.61 166.65 -1.6%
MMTC Ltd. Consolidated 2022-03 0.00 27.90 -0.4%
Landmark Cars Ltd. Consolidated 2022-03 31.70 546.90 +7.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.28 207.95 +2.7%
SIRCA Paints India Ltd. Consolidated 2022-03 12.99 645.35 +0.3%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.89 40.80 -3.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 69,420.18 1,750.00 +0.5%
Redington Ltd. Consolidated 2022-03 62,644.01 166.65 -1.6%
MMTC Ltd. Consolidated 2022-03 11,796.24 27.90 -0.4%
Landmark Cars Ltd. Consolidated 2022-03 2,976.52 546.90 +7.4%
Optiemus Infracom Ltd. Consolidated 2022-03 471.63 207.95 +2.7%
SIRCA Paints India Ltd. Consolidated 2022-03 200.02 645.35 +0.3%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 56.55 40.80 -3.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 475.37 1,750.00 +0.5%
Redington Ltd. Consolidated 2022-03 1,314.87 166.65 -1.6%
MMTC Ltd. Consolidated 2022-03 -262.38 27.90 -0.4%
Landmark Cars Ltd. Consolidated 2022-03 66.18 546.90 +7.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.92 207.95 +2.7%
SIRCA Paints India Ltd. Consolidated 2022-03 27.72 645.35 +0.3%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 1.43 40.80 -3.8%

FAQ's On Checkpoint Trends Ltd.

What is Rubra Medicaments share price?

Can I buy Rubra Medicaments shares now?

What is the Market Cap of Rubra Medicaments?

What are the key metrics to analyse Rubra Medicaments?

What is the 52 Week High and Low of Rubra Medicaments?